Arizona State Retirement System Sells 2,861 Shares of Tenet Healthcare Corporation $THC

Arizona State Retirement System trimmed its stake in Tenet Healthcare Corporation (NYSE:THC) by 10.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 24,625 shares of the company’s stock after selling 2,861 shares during the period. Arizona State Retirement System’s holdings in Tenet Healthcare were worth $4,893,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Eminence Capital LP bought a new stake in shares of Tenet Healthcare in the 3rd quarter worth about $225,263,000. Boston Partners lifted its holdings in shares of Tenet Healthcare by 38.8% in the 3rd quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after acquiring an additional 880,413 shares during the last quarter. AQR Capital Management LLC lifted its holdings in shares of Tenet Healthcare by 62.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after acquiring an additional 720,160 shares during the last quarter. Alliancebernstein L.P. lifted its holdings in shares of Tenet Healthcare by 375.7% in the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock worth $139,085,000 after acquiring an additional 624,125 shares during the last quarter. Finally, WCM Investment Management LLC lifted its holdings in shares of Tenet Healthcare by 244.4% in the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after acquiring an additional 362,083 shares during the last quarter. 95.44% of the stock is owned by institutional investors.

Analysts Set New Price Targets

THC has been the subject of a number of research analyst reports. Leerink Partners raised their price target on Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a research note on Friday, February 20th. Mizuho raised their price target on Tenet Healthcare from $235.00 to $265.00 and gave the stock an “outperform” rating in a research note on Thursday, March 12th. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Finally, Guggenheim lifted their price objective on shares of Tenet Healthcare from $271.00 to $283.00 and gave the company a “buy” rating in a report on Thursday, March 12th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $250.56.

Tenet Healthcare Trading Up 2.5%

NYSE:THC opened at $185.27 on Tuesday. Tenet Healthcare Corporation has a one year low of $121.83 and a one year high of $247.21. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The firm has a market cap of $16.23 billion, a P/E ratio of 11.96, a P/E/G ratio of 1.36 and a beta of 1.49. The firm has a 50-day simple moving average of $210.51 and a 200-day simple moving average of $204.62.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating the consensus estimate of $4.08 by $0.62. The business had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities analysts anticipate that Tenet Healthcare Corporation will post 17.31 EPS for the current fiscal year.

Insider Activity

In other news, insider R. Scott Ramsey sold 8,017 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Paola M. Arbour sold 6,500 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the sale, the executive vice president directly owned 29,291 shares in the company, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 46,517 shares of company stock valued at $10,943,111. Company insiders own 0.81% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.